Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.60 |
| ▸ | CA2 | P00918 | 8/20 | 0.60 |
| ▸ | CA9 | Q16790 | 6/20 | 0.60 |
| ▸ | CA12 | O43570 | 5/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.60 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | CA7 | P43166 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 3/20 | 0.45 |
| ▸ | CA6 | P23280 | 2/20 | 0.45 |
| ▸ | CA5A | P35218 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.44 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29469832 | 1.00 | CA1 (0.60) | CA1CA2CA9CA12CA14 | |
| Fluoride SCHEMBL28042437 | 0.98 | CA1 (0.58) | CA1CA2CA9CA12CA14 | |
| SCHEMBL27518574 | 0.86 | CA1 (0.50) | CA1CA2CA9CA12CA14 | |
| SCHEMBL29469878 | 0.85 | CA1 (0.50) | CA1CA2CA9CA12CA14 | |
| SCHEMBL1649916 | 0.85 | CA1 (0.50) | CA1CA2CA9CA12CA14 | |
| SCHEMBL10749628 | 0.84 | PTGES2 (0.46) | CA1CA2CA9CA12CA14 | |
| SCHEMBL7108847 | 0.84 | ALDH1A1 (0.50) | CA1CA2CA9CA12CA14 | |
| SCHEMBL1334805 | 0.84 | CYP2C9 (0.56) | CA1CA2CA9CA12CA14 | |
| SCHEMBL31411936 | 0.84 | CA1 (0.54) | CA1CA2CA9CA12CA14 | |
| SCHEMBL28115347 | 0.84 | CA12 (0.54) | CA1CA2CA9CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110642791-A | Sulfonylurea compound, preparation method thereof and application thereof in preparing herbicide | 南开大学 | 2020-01-03 | — | — | CN | claimed |
| WO-2026099404-A1 | SULFONYLUREA DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER | QUBIT PHARMACEUTICALS (FR) | 2026-05-15 | — | — | WO | disclosed |
| EP-4741375-A1 | SULFONYLUREA DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER | Qubit Pharmaceuticals (FR) | 2026-05-13 | — | — | EP | disclosed |
| EP-4229045-B1 | SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER | BROAD INST INC (US) | 2025-11-12 | — | — | EP | disclosed |
| US-12357603-B2 | Acyl sulfonamides for treating cancer | BAYER AKTIENGESELLSCHAFT (DE) | 2025-07-15 | — | — | US | disclosed |
| EP-4472682-A1 | SENSORS FOR ANTIMICROBIAL BIPHASIC POLYMERS, AND SYSTEMS AND METHODS INCORPORATING THE SAME | HRL Laboratories, LLC (US) | 2024-12-11 | — | — | EP | disclosed |
| US-20240287048-A1 | SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER | BAYER AKTIENGESELLSCHAFT (DE) | 2024-08-29 | — | — | US | disclosed |
| US-20240279207-A1 | SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER | BAYER AKTIENGESELLSCHAFT (DE) | 2024-08-22 | — | — | US | disclosed |
| US-12011444-B2 | N-substituted indole derivatives as PGE2 receptor modulators | IDORSIA PHARMACEUTICALS LTD (CH) | 2024-06-18 | — | — | US | disclosed |
| US-11760722-B2 | Inhibitors of cysteine proteases and methods of use thereof | ASCLETIS BIOSCIENCE CO., LTD. (CN) | 2023-09-19 | — | — | US | disclosed |
| CN-1240429-A | Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors | AMERICAN CYANAMID CO (US) | 2000-01-05 | — | — | CN | disclosed |
| US-5990353-A | DEMETALLIZING AN ARYLSULFONAMIDE ALKALI METAL SALT WITH AN AROMATIC ISOCYANATE COMPOUND IN AT LEAST ONE SOLVENT; USE AS A COLOR DEVELOPER FOR A THERMAL RECORDING MATERIAL WITH IMPROVED OIL RESISTANCE AND NONPLASTICIZED | YAMAMOTO CHEMICALS, INC. (JP) | 1999-11-23 | — | — | US | disclosed |
| EP-0879816-A1 | Process for producing arylsulfonylureide compounds | Yamamoto Chemicals, Inc. (JP) | 1998-11-25 | — | — | EP | disclosed |
| EP-0694041-A1 | A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING N-ALPHA-METHYLARGININE | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-01-31 | — | — | EP | disclosed |
| EP-0327318-B1 | Heat-sensitive recording materials | FUJI PHOTO FILM CO LTD (JP) | 1995-07-19 | — | — | EP | disclosed |
| US-4975353-A | Support and layer of diazo compound, coupling component for coloration and basic compound | FUJI PHOTO FILM CO., LTD. (JP) | 1990-12-04 | — | — | US | disclosed |
| US-4895826-A | STORAGE STABILITY; DISCOLORATION INHIBITION | FUJI PHOTO FILM CO., LTD. (JP) | 1990-01-23 | — | — | US | disclosed |
| EP-0327318-A2 | Heat-sensitive recording materials | FUJI PHOTO FILM CO., LTD. (JP) | 1989-08-09 | — | — | EP | disclosed |
| EP-0323887-A2 | Heat-sensitive diazo recording materials | FUJI PHOTO FILM CO., LTD. (JP) | 1989-07-12 | — | — | EP | disclosed |
| EP-0288240-A2 | Heat-sensitive diazo recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1988-10-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287048-A1 | SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER | KAT6A, KAT6B, KAT2A | CA1 2072/4885CA2 2985/4885CA9 2304/4885 |
| US-12011444-B2 | N-substituted indole derivatives as PGE2 receptor modulators | PTGER1, PTGER4, PTGER2 | CA1 4424/4885CA2 2718/4885CA9 4465/4885 |
| US-12357603-B2 | Acyl sulfonamides for treating cancer | KAT6A, KAT6B, KAT2A | CA1 1716/4885CA2 2884/4885CA9 2045/4885 |
| US-20240279207-A1 | SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER | KAT6A, KAT6B, KAT2A | CA1 1714/4885CA2 2865/4885CA9 1575/4885 |
| US-11760722-B2 | Inhibitors of cysteine proteases and methods of use thereof | SERPINB1, PREP, DNPEP | CA1 197/4885CA2 661/4885CA9 550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.